204 related articles for article (PubMed ID: 20847046)
1. Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.
Ma B; Nussinov R
J Biol Chem; 2010 Nov; 285(47):37102-10. PubMed ID: 20847046
[TBL] [Abstract][Full Text] [Related]
2. Abeta-globulomers are formed independently of the fibril pathway.
Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic structures of Alzheimer's β-amyloid globulomers.
Yu X; Zheng J
PLoS One; 2011; 6(6):e20575. PubMed ID: 21687730
[TBL] [Abstract][Full Text] [Related]
4. Identifying the Template for Oligomer to Fibril Conversion for Amyloid-β (1-42) Oligomers using Hamiltonian Replica Exchange Molecular Dynamics.
Saha D; Jana B
Chemphyschem; 2022 Dec; 23(24):e202200393. PubMed ID: 36052514
[TBL] [Abstract][Full Text] [Related]
5. EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure.
Jang C; Portugal Barron D; Duo L; Ma C; Seabaugh H; Guo Z
ACS Chem Neurosci; 2024 Jan; 15(1):86-97. PubMed ID: 38109787
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
[TBL] [Abstract][Full Text] [Related]
7. Role of water in protein aggregation and amyloid polymorphism.
Thirumalai D; Reddy G; Straub JE
Acc Chem Res; 2012 Jan; 45(1):83-92. PubMed ID: 21761818
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.
Ma B; Nussinov R
J Biol Chem; 2011 Sep; 286(39):34244-53. PubMed ID: 21832091
[TBL] [Abstract][Full Text] [Related]
9. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
10. Aggregation and structure of amyloid β-protein.
Ono K; Watanabe-Nakayama T
Neurochem Int; 2021 Dec; 151():105208. PubMed ID: 34655726
[TBL] [Abstract][Full Text] [Related]
11. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
Rosenman DJ; Connors CR; Chen W; Wang C; García AE
J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
[TBL] [Abstract][Full Text] [Related]
12. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
Ladiwala AR; Litt J; Kane RS; Aucoin DS; Smith SO; Ranjan S; Davis J; Van Nostrand WE; Tessier PM
J Biol Chem; 2012 Jul; 287(29):24765-73. PubMed ID: 22547072
[TBL] [Abstract][Full Text] [Related]
13. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
Tycko R; Wickner RB
Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
[TBL] [Abstract][Full Text] [Related]
14. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation.
Vitalis A; Caflisch A
J Mol Biol; 2010 Oct; 403(1):148-165. PubMed ID: 20709081
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
16. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
[TBL] [Abstract][Full Text] [Related]
17. A molecular model of Alzheimer amyloid beta-peptide fibril formation.
Tjernberg LO; Callaway DJ; Tjernberg A; Hahne S; Lilliehöök C; Terenius L; Thyberg J; Nordstedt C
J Biol Chem; 1999 Apr; 274(18):12619-25. PubMed ID: 10212241
[TBL] [Abstract][Full Text] [Related]
18. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
19. Stabilization Mechanism for a Nonfibrillar Amyloid β Oligomer Based on Formation of a Hydrophobic Core Determined by Dissipative Particle Dynamics.
Kawai R; Chiba S; Okuwaki K; Kanada R; Doi H; Ono M; Mochizuki Y; Okuno Y
ACS Chem Neurosci; 2020 Feb; 11(3):385-394. PubMed ID: 31899612
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
